Related Experiment Video
Updated: Jul 17, 2026
09:31
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
9.2K
Mesothelioma: morphologic and immunohistochemical findings
1Department of Pathology, JPPN 1401 Vancouver General Hospital, 910 West 10th Ave, V5Z 1M9, Vancouver, BC, Canada. achurg@mail.ubc.ca.
Pathologie (Heidelberg, Germany)
|April 3, 2024
Summary
Diagnosing mesothelioma has new insights. A combination of HEG1 and claudin-4 immunostains accurately distinguishes epithelioid mesothelioma from lung cancer. Genetic markers like BAP1 help identify benign versus malignant mesothelial tumors.
Area of Science:
- Pathology
- Oncology
- Diagnostic Medicine
Background:
- The diagnosis of mesothelioma relies on clinical, radiologic, and immunohistochemical findings.
- Previous markers for distinguishing mesothelioma from metastatic carcinoma have shown limited specificity.
- Nodular pleural thickening on CT scans is a key radiologic indicator of malignancy.
Purpose of the Study:
- To review current diagnostic concepts for mesothelioma.
- To evaluate the efficacy of novel immunohistochemical markers in mesothelioma diagnosis.
- To differentiate between benign and malignant mesothelial proliferations.
Main Methods:
- Review of existing literature on mesothelioma diagnosis.
- Analysis of immunohistochemical marker performance, including HEG1, claudin-4, BAP1, MTAP, and NF2/Merlin.
- Evaluation of fluorescence in situ hybridization (FISH) for CDKN2A and NF2.
Main Results:
- The combination of HEG1 (clone SKM9-2) and claudin-4 staining demonstrates high accuracy in differentiating epithelioid mesotheliomas from non-small-cell lung carcinomas.
- BAP1, MTAP (or CDKN2A FISH), and NF2/Merlin (or NF2 FISH) are valuable for distinguishing benign from malignant mesothelial proliferations.
- Mesothelioma in situ, characterized by BAP1/MTAP loss, is recognized and likely progresses to invasive disease.
Conclusions:
- A dual immunostain of HEG1 and claudin-4 offers a precise method for diagnosing epithelioid mesothelioma.
- Genetic and immunohistochemical markers like BAP1 are crucial for identifying malignant mesothelial proliferations.
- Accurate diagnosis of mesothelioma requires careful integration of clinical, radiologic, and molecular data, with specific considerations for high-grade serous carcinoma and sarcomatoid subtypes.
